Patents Represented by Attorney Jackson & Co., LLP
  • Patent number: 8226891
    Abstract: Method and apparatus for performing a discrete glucose testing and bolus dosage determination including a glucose meter with bolus calculation function are provided.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: July 24, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Mark K. Sloan, R. Curtis Jennewine
  • Patent number: 8226555
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: July 24, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 8229766
    Abstract: A variable resolution grid provides a mechanism for focusing specific concentrations of risk exposure on a geographical grid to determine projected loss caused by a particular catastrophe. The geographic grid provides a stable base map by using latitudes and longitudes to define the grid points and cells. Each cell is assigned a geographic identifier or geocode that identifies the location of the cell and its associated resolution. The resolution of the grid may be varied depending in part, on the resolution of any available of hazard data.
    Type: Grant
    Filed: August 5, 2004
    Date of Patent: July 24, 2012
    Assignee: Risk Management Solutions, Inc.
    Inventors: David Carttar, Mohan Sharma, Surya Gunturi, Robert Muir-Wood, Pane Stojanovski
  • Patent number: 8223021
    Abstract: A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: July 17, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy T. Goodnow, Lei (Lawrence) He
  • Patent number: 8224413
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: July 17, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 8224415
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include processing sampled data from analyte sensor, determining a single, fixed, normal sensitivity value associated with the analyte sensor, estimating a windowed offset value associated with the analyte sensor for each available sampled data cluster, computing a time varying offset based on the estimated windowed offset value, and applying the time varying offset and the determined normal sensitivity value to the processed sampled data to estimate an analyte level for the sensor.
    Type: Grant
    Filed: January 29, 2009
    Date of Patent: July 17, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Erwin Satrya Budiman
  • Patent number: 8216137
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Grant
    Filed: July 20, 2009
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Erwin S. Budiman
  • Patent number: 8216138
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Geoffrey V. McGarraugh
  • Patent number: 8219175
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Patent number: 8219174
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Patent number: 8219173
    Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
  • Patent number: 8211016
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: July 3, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Erwin S. Budiman
  • Patent number: 8206296
    Abstract: Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: June 26, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventor: R. Curtis Jennewine
  • Patent number: 8196607
    Abstract: A subsea coupling comprises a male coupler having a probe and a female coupler comprising a socket for the reception of the probe. The couplers each include a valve which is openable on mating of the couplers to provide communication with the socket. The socket includes a recess accommodating an annular seal for providing a radial seal between the probe and the socket. In one embodiment the leading edge of the probe includes at least one relief channel for allowing the escape of hydraulic fluid entrapped between the probe, the seal and the recess when the couplers are made up. There may be a stand-off ring disposed between one end of the recess and the inner side of the seal. In another embodiment the relief channel is provided in the socket.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: June 12, 2012
    Inventor: Douglas Frederick Kirkman
  • Patent number: 8187183
    Abstract: A continuous glucose monitoring system including a sensor configured to detect one or more glucose levels, a transmitter operatively coupled to the sensor, the transmitter configured to receive the detected one or more glucose levels, the transmitter further configured to transmit signals corresponding to the detected one or more glucose levels, and a receiver operatively coupled to the transmitter configured to receive transmitted signals corresponding to the detected one or more glucose levels, and methods thereof, are disclosed. In one aspect, the transmitter may be configured to transmit a current data point and at least one previous data point, the current data point and the at least one previous data point corresponding to the detected one or more glucose levels.
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: May 29, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Robert Y. Jin, Mark K. Sloan
  • Patent number: 8185181
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: May 22, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Patent number: 8177716
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: May 15, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 8175673
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: November 9, 2009
    Date of Patent: May 8, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 8168051
    Abstract: A process for the manufacture of small sensors with reproducible surfaces, including electrochemical sensors. One process includes forming channels in the surface of a substrate and disposing a conductive material in the channels to form an electrode. The conductive material can also be formed on the substrate by other impact and non-impact methods. In a preferred embodiment, the method includes cutting the substrate to form a sensor having a connector portion and a transcutaneous portion, the two portions having edges that define one continuous straight line.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: May 1, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke
  • Patent number: 8162829
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: April 24, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman